Management and outcome of peptic ulcers or erosions in patients receiving a combination of aspirin plus clopidogrel.
Ng, Fook Hong; Chan, Pierre; Kwanching, Chi Pong; Loo, Ching Kong; Cheung, Ting Kin; Wong, Siu Yin; Kng, Carolyn; Ng, Ka Man; Lai, Sik To; Wong, Benjamin Chun Yu.
; 43(9): 679-86, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18807129
New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study.
Ability of rabeprazole to prevent gastric mucosal damage from clopidogrel and low doses of aspirin depends on CYP2C19 genotype.
Gastrointestinal events with clopidogrel: a nationwide population-based cohort study.
Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: an 86-year-old woman with peptic ulcer disease.
Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.
A randomized, double-blind, placebo-controlled study of rebamipide for gastric mucosal injury taking aspirin with or without clopidogrel.
[The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].
Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
A Meta-analysis of the Impact of Aspirin, Clopidogrel, and Dual Antiplatelet Therapy on Bleeding Complications in Noncardiac Surgery.